REVIEW
Accepted on 31 Jul 2025
Death-Associated Protein Kinase 1 (DAPK1): A Double-Edged Sword in Health and Disease
doi 10.3389/fimmu.2025.1593394
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- The Molecular Mechanisms and Therapeutic Implications of Protein Kinase Inhibitors in Cancer Therapy
The Molecular Mechanisms and Therapeutic Implications of Protein Kinase Inhibitors in Cancer Therapy
2,800
Total downloads
11k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 23 Jul 2025
Dual PI3K/mTOR inhibitor NVP-BEZ235 induces cell cycle arrest via autophagy mediated protein degradation of RPL19 in nephroblastoma cell
doi 10.3389/fphar.2025.1588722
- 707 views
REVIEW
Published on 19 Jun 2025
PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities
doi 10.3389/fimmu.2025.1602752
- 1,232 views
PERSPECTIVE
Published on 05 Dec 2024
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
doi 10.3389/fonc.2024.1459737
- 2,395 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Nov 2024
COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity
doi 10.3389/fimmu.2024.1452035
- 1,301 views
ORIGINAL RESEARCH
Published on 01 Nov 2024
The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy
doi 10.3389/fimmu.2024.1451796
- 1,555 views
REVIEW
Published on 12 Aug 2024
Biological functions and therapeutic potential of CKS2 in human cancer
doi 10.3389/fonc.2024.1424569
- 1,297 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.